feedback welcome

Imipramine-vortioxetine

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][checked revision]
 
Line 3: Line 3:
| to = vortioxetine  
| to = vortioxetine  
| stop =  
| stop =  
-
* '''Before day 1:''' gradually reduce dosage of imipramine to a maximum of 75 mg/day.
+
{{stopImipramine}}
-
* '''Day 1:''' reduce dosage of imipramine to 50 mg/day.
+
-
* '''Day 3:''' reduce dosage of imipramine to 25 mg/day.
+
-
* '''Day 8:''' stop administration of imipramine.
+
| start =  
| start =  
* A wash-out period is not necessary.
* A wash-out period is not necessary.
-
* '''Day 8:''' start administration of vortioxetine in a low dosage of 10 mg/day.
+
* '''Day 9:''' start administration of vortioxetine in a low dosage of 10 mg/day.
| info =  
| info =  
-
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.
+
* {{theorSS}}
-
{{review}}
+
}}
}}

Current revision as of 12:47, 4 November 2015

Imipramine
Type Antidepressant
Group TCA
links
Medscape Imipramine
PubChem 3696
PubMed Imipramine
Kompas (Dutch) Imipramine
Wikipedia Imipramine
Vortioxetine
Type Antidepressant
Group SMS
links
Medscape Vortioxetine
PubChem 9966051
PubMed Vortioxetine
Kompas (Dutch) Vortioxetine
Wikipedia Vortioxetine

Switch medication from imipramine to vortioxetine.

Nietinrijdenbord.png Stop imipramine
Eenrichtingbord.png Start vortioxetine
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About